NasdaqCM - Delayed Quote USD

SAB Biotherapeutics, Inc. (SABSW)

Compare
0.0368
+0.0048
+(15.00%)
At close: January 31 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
51,775.4510
38,075.3200
28,917.6170
13,393.2030
-20,556.7970
Operating Income
-51,775.4510
-38,075.3200
-28,917.6170
-13,393.2030
20,556.7970
Net Non Operating Interest Income Expense
1,308.2660
269.6820
-230.5120
-271.3440
-443.0200
Other Income Expense
4,899.8120
-4,388.1480
10,432.9540
-3,479.9840
3.9960
Pretax Income
-45,567.3730
-42,193.7860
-18,715.1750
-17,144.5310
20,117.7730
Tax Provision
--
--
25.6290
--
--
Net Income Common Stockholders
-45,567.3730
-42,193.7860
-18,740.8040
-17,144.5310
20,117.7730
Diluted NI Available to Com Stockholders
-45,567.3730
-42,193.7860
-18,740.8040
-17,144.5310
20,117.7730
Total Operating Income as Reported
-51,775.4510
-38,075.3200
-28,917.6170
-13,393.2030
20,556.7970
Total Expenses
51,775.4510
38,075.3200
28,917.6170
13,393.2030
-20,556.7970
Net Income from Continuing & Discontinued Operation
-45,567.3730
-42,193.7860
-18,740.8040
-17,144.5310
20,117.7730
Normalized Income
-48,531.6710
-37,370.5490
-26,956.1720
-13,659.0590
20,117.7730
Interest Income
1,633.6700
584.9660
71.0720
23.1150
26.1310
Interest Expense
325.4040
315.2840
301.5840
294.4590
469.1510
Net Interest Income
1,308.2660
269.6820
-230.5120
-271.3440
-443.0200
EBIT
-45,241.9690
-41,878.5020
-18,413.5910
-16,850.0720
20,586.9240
EBITDA
-40,290.6860
-38,133.2200
-15,121.7130
-15,196.4750
21,135.1020
Reconciled Depreciation
4,951.2830
3,745.2820
3,291.8780
1,653.5970
548.1780
Net Income from Continuing Operation Net Minority Interest
-45,567.3730
-42,193.7860
-18,740.8040
-17,144.5310
20,117.7730
Total Unusual Items Excluding Goodwill
2,964.2980
-4,823.2370
10,399.2000
-3,485.4720
--
Total Unusual Items
2,964.2980
-4,823.2370
10,399.2000
-3,485.4720
--
Normalized EBITDA
-43,254.9840
-33,309.9830
-25,520.9130
-11,711.0030
21,135.1020
Tax Rate for Calcs
--
--
0.0002
--
0.0003
Tax Effect of Unusual Items
--
--
2,183.8320
--
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

688278.SS Xiamen Amoytop Biotech Co., Ltd.
80.88
+0.99%
 
ISCO International Stem Cell Corporation
0.1100
0.00%
 
NKGNW NKGen Biotech, Inc.
0.1141
+14.10%
 
WXXWY WuXi Biologics (Cayman) Inc.
4.7800
+0.63%
 
CDTTW Conduit Pharmaceuticals Inc.
0.0131
+0.77%
 
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
 
DNABW Ginkgo Bioworks Holdings, Inc.
0.0085
-34.62%
 
MTVA MetaVia Inc.
1.8100
-8.12%
 
XBIO Xenetic Biosciences, Inc.
4.3100
+0.70%
 
FBLG FibroBiologics, Inc.
1.6100
-3.59%